$ZVIA

Zevia PBC

alphai earnings readsecond quarter 2026 · AUG 5Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds OutlookVerdict: mixed

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $ZVIA in the last 7 days.

No SEC Form 4 filings for $ZVIA in the last 30 days.

See all $ZVIA insider activity →
Med

Activist investor calls on Zevia board to sell business

Activist investor Kanen Wealth Management, which owns about 4% of Zevia, urged the board to review strategy and consider selling the US zero-sugar soft-drinks maker, citing a sale value of $2.75 to $3.75 per share versus about $1.30. Kanen criticized governance and succession. Zevia reported Q2 net sales of $45m (+1.1% YoY) and wider losses, and kept FY net sales guidance of $170m to $175m.

Zevia stock jumps as Kanen urges sale of beverage maker

Zevia Pbc (NYSE:ZVIA) shares rose 6.9% premarket after Kanen Wealth Management, holding about 4% of the company, urged the board to explore a sale. In a letter, Kanen estimated a sale value of $2.75 to $3.75 per share, citing category deals and Zevia’s declining net sales.

Zevia (ZVIA) Q2 2026 Earnings Call Transcript

Zevia PBC (ZVIA) reported Q2 2026 net sales of $45.0 million, up 1.1% on pricing actions, with adjusted EBITDA of $0.5 million. Net loss was $2.9 million. Q3 guidance calls for net sales of $44 million to $46 million and negative adjusted EBITDA of $3.0 million to $3.5 million, with full-year sales of $170 million to $175 million.

ZVIA sentiment & insider activity

Recent ZVIA coverage spans earnings, corporate actions and financial news.

What's driving ZVIA

  • The activist’s explicit sale call and valuation range can pressure the board and increase near-term probability of strategic alternatives, raising takeover or process speculation risk.

    yahoo.com · Aug 17, 2026

  • Activist pressure to pursue a sale can re-rate takeover odds and near-term valuation, especially with a stated per-share value range.

    investing.com · Aug 14, 2026

  • Near-term profitability is expected to worsen despite modest top-line growth, with margin pressure tied to aluminum costs and higher promotional activity.

    fool.com · Aug 13, 2026

  • Management emphasized a singles go-to-market push starting early 2027, while maintaining 2026 guidance despite fuel and aluminum cost pressure.

    yahoo.com · Aug 9, 2026

  • The beat plus optimistic next-quarter revenue guidance is a near-term positive catalyst, but the stock reportedly fell 2.3% immediately after results.

    financialcontent.com · Aug 5, 2026

alphai scores every news story that mentions ZVIA with an AI model for sentiment and relevance, and aggregates insider trades from Zevia PBC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ZVIA

Score
$ZVIAMed

Activist investor calls on Zevia board to sell business

Activist investor Kanen Wealth Management, which owns about 4% of Zevia, urged the board to review strategy and consider selling the US zero-sugar soft-drinks maker, citing a sale value of $2.75 to $3.75 per share versus about $1.30. Kanen criticized governance and succession. Zevia reported Q2 net sales of $45m (+1.1% YoY) and wider losses, and kept FY net sales guidance of $170m to $175m.

$ZVIAMedAI 9/10

Zevia (ZVIA) Q2 2026 Earnings Call Transcript

Zevia PBC (ZVIA) reported Q2 2026 net sales of $45.0 million, up 1.1% on pricing actions, with adjusted EBITDA of $0.5 million. Net loss was $2.9 million. Q3 guidance calls for net sales of $44 million to $46 million and negative adjusted EBITDA of $3.0 million to $3.5 million, with full-year sales of $170 million to $175 million.

$ZVIAMed

Zevia PBC Q2 Earnings Call Highlights

Zevia PBC (ZVIA) reported Q2 expense details and cash of about $28.5M plus an undrawn $20M revolver. Management highlighted a push to expand singles, estimating up to ~$80M opportunity. Q3 guidance calls for net sales of $44M to $46M and adjusted EBITDA loss of $3M to $3.5M. Full-year 2026 net sales $170M to $175M and adjusted EBITDA loss $2M to $4M were maintained.

$ZVIAHigh

Zevia PBC (ZVIA): Results of Operations and Financial Condition

Zevia PBC (ZVIA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds Outlook LOS ANGELES – August 5, 2026 (BUSINESS WIRE) – Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the Company bringing naturally delicious, zero sugar, c

$ZVIALow

Zevia PBC (ZVIA): Submission of Matters to a Vote of Security Holders

Zevia PBC (ZVIA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. zvia20260612_8k.htm false 0001854139 0001854139 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Repo

$ZVIAMed

Zevia PBC (ZVIA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Zevia PBC (ZVIA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. zvia20260613_8k.htm false 0001854139 0001854139 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Repo

Related tickers